netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 20 of 20


Details
UPD sitematrix Changed from 0 to
27/07/2022 15:35:30
(DavidS )
UPD DeletedItem Changed from N to Y
27/07/2022 15:35:30
(DavidS )
UPD Olaratumab (Lartuvo®) hidden
27/07/2022 15:35:30
(DavidS )
UPD sitematrix Changed from 0 to
27/07/2022 15:17:00
(LoweryM )
UPD FurtherInformation Changed from

  • 10 mg/mL concentrate for solution for infusion

  • Approved for the treatment of advanced soft tissue sarcoma in combination with doxorubicin in line with NICE


**Notice of

27/07/2022 15:17:00
(LoweryM )
UPD Olaratumab (Lartuvo®) formatting
27/07/2022 15:17:00
(LoweryM )
UPD sitematrix Changed from 0 to
26/04/2022 12:06:49
(DavidS )
UPD FurtherInformation Changed from
  • 10 mg/mL concentrate for solution for infusion
  • Approved for the treatment of advanced soft tissue sarcoma in combination with doxorubicin in line with NICE

**Notice o

26/04/2022 12:06:49
(DavidS )
UPD Olaratumab (Lartuvo®) updated
26/04/2022 12:06:49
(DavidS )
UPD NHSE Changed from N
26/04/2022 11:35:32
(DavidS )
UPD sitematrix Changed from 0 to
26/04/2022 11:35:32
(DavidS )
UPD isCyto Changed from 0 to 1
26/04/2022 11:35:32
(DavidS )
UPD Olaratumab (Lartuvo®) updated
26/04/2022 11:35:32
(DavidS )
UPD Olaratumab (Lartuvo®) updated
20/05/2021 13:44:55
(LoweryM )
UPD Olaratumab (Lartuvo®) formatting updated
19/05/2021 16:46:53
(DavidS )
UPD Olaratumab (Lartuvo®) updated
29/10/2019 14:49:42
(DavidS )
UPD Olaratumab (Lartuvo®) updated
29/10/2019 14:49:07
(DavidS )
UPD Published from Draft Mode
27/10/2017 15:26:27
(DavidS )
LDL Link Added : NICE TA465 Olaratumab in combination with doxorubicin for treating advanced soft tissue sarcoma : https://www.nice.org.uk/guidance/ta465
26/10/2017 17:18:19
(DavidS )
ADD Olaratumab (Lartuvo®) NICE TA465
26/10/2017 17:17:42
(DavidS )

 

 

netFormulary